| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 37.172 | 522.834 | 1.557.556 | 309.736 | 150.446 |
| Total Income - EUR | - | - | - | - | 0 | 37.172 | 522.909 | 1.557.557 | 309.742 | 150.446 |
| Total Expenses - EUR | - | - | - | - | 316 | 45.606 | 426.569 | 1.474.142 | 793.020 | 262.876 |
| Gross Profit/Loss - EUR | - | - | - | - | -316 | -8.434 | 96.340 | 83.415 | -483.278 | -112.429 |
| Net Profit/Loss - EUR | - | - | - | - | -316 | -8.662 | 91.741 | 70.473 | -483.278 | -112.429 |
| Employees | - | - | - | - | 0 | 3 | 3 | 4 | 5 | 5 |
Check the financial reports for the company - Docplant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 2.051 | 984 | 1.021 | 1.015 |
| Current Assets | - | - | - | - | 42 | 11.495 | 283.683 | 1.195.732 | 220.100 | 82.257 |
| Inventories | - | - | - | - | 0 | 4.854 | 55.623 | 132.405 | 39.272 | 8.234 |
| Receivables | - | - | - | - | 0 | 5.679 | 199.797 | 1.010.745 | 138.113 | 74.023 |
| Cash | - | - | - | - | 42 | 963 | 28.263 | 52.582 | 42.716 | 0 |
| Shareholders Funds | - | - | - | - | -274 | -8.931 | 92.186 | 111.195 | -372.451 | -363.762 |
| Social Capital | - | - | - | - | 42 | 41 | 9.218 | 12.329 | 12.292 | 12.223 |
| Debts | - | - | - | - | 316 | 20.426 | 193.548 | 1.085.521 | 593.572 | 447.034 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4621 - 4621" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Docplant S.r.l.